Americas
20 February 2025 Market leader settles patent disputes with generic drug makers, blocking the release of versions of two key products | More than 80% of HIV patients in the US use Gilead’s treatments.
18 February 2025
6 February 2025
23 January 2025
21 January 2025
Latest Features
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Americas
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.
Americas
Brazil’s updated regulations for its flagship partnerships programme marks a renewed effort to strengthen the nation's health sector, says Rob Rodrigues of RNA Law.
Americas
An ambiguous decision by the Supreme Court has paved the way for frivolous petitions for compensation and clarity is needed, say Daniel Sanchez and Karla Olvera of Olivares.
Americas
Securing IP protection in Brazil for the ‘bio-ink’ used to print new human tissue has challenges but composition is key, say Priscila Kashiwabara and Breno Souza of Kasznar Leonardos.
Americas
If the right steps are taken, the US International Trade Commission is an attractive option for firms fearing the loss of their valuable IP, say Mary Prendergast, Mark Whitaker and Nicole Ang of Morrison Foerster.
Americas
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general.
Americas
A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
More News
16 January 2025 A district court of appeal has paused MSN Pharmaceuticals’ launch | Result comes days after the Federal Circuit restored Novartis’ patent and overturned a decision in favour of MSN | Request is one in a flurry of filings between the pair over the heart-failure drug.
14 January 2025 Federal circuit reverses district court’s ruling to revive combination patent | Novartis says patent has paediatric exclusivity expiring in July 2025.
9 January 2025 PTAB determines all but one of challenged claims unpatentable | Decision is latest instalment in clash over electrocardiogram technology | Apple bid to stop ‘AliveCor’s rampant infringement’ backfires.
17 December 2024 Regeneron inks deal over suit concerning a protein for testing COVID-19 treatments | BioNTech aims to resolve university dispute over patented tech used in the Comirnaty vaccine.
21 November 2024 Agreement provides for €140 million in upfront and additional payments to Cytokinetics and up to €490 million in milestone payments, with tiered royalties on future sales | “Important regional deal” comes as Bayer’s new partner eyes US and European markets.
21 November 2024 The firm brings two life sciences and tech experts to its litigation department | Pair bring combined experience of 45 years from Weil, Gotshal & Manges | Duo offer expertise handling cases for pharmaceutical, biotechnology, and technology clients.
19 November 2024 Judges at Munich Local Division determined that Meril infringed Edwards Lifesciences’ patent | Meril ordered to stop selling and recall product as well as pay damages.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox